NIH-funded research R01 grant

Quick detection of Hepatitis C virus using advanced technology

Official title: Rapid point of care Hepatitis C virus detection using a long-lasting luminescent cascade signal amplification

Funded at Brigham and Women's Hospital · NIH-11025330 · Data updated 2026-11-12

This study is working on a quick and easy test to help find Hepatitis C infections, especially for people in underserved communities like American Indians and Alaska Natives, so they can get the treatment they need sooner.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startNovember 22, 2024
Project endOctober 31, 2029
Funding year2025
Award (this year)$884,453
NIH project number1R01AI187513-01
Project IDNIH-11025330 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for Hepatitis C, particularly those from American Indian and Alaska Native populations.

Less likely to help

Patients who are already diagnosed and receiving treatment for Hepatitis C may not benefit directly from this research.

What this research studies

This research focuses on developing a rapid point-of-care test for detecting Hepatitis C virus (HCV) infections, which is crucial for timely treatment. The approach utilizes a long-lasting luminescent cascade signal amplification method to enhance the sensitivity and specificity of HCV antigen detection. By streamlining the testing process, the research aims to improve diagnosis rates, particularly in underserved populations such as American Indians and Alaska Natives. The goal is to facilitate early detection and management of HCV, ultimately reducing the burden of the disease.

Why it matters

Potential benefit: If successful, this research could lead to faster and more accurate diagnosis of Hepatitis C, improving treatment outcomes for patients.

How similar studies have gone: Previous research has shown promise in rapid point-of-care testing for other infectious diseases, indicating potential success for this novel approach in HCV detection.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Shafiee, Hadi — Brigham and Women's Hospital
  • Study coordinator: Shafiee, Hadi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.